NordiQC, the Nordic Immunohistochemistry Quality Control Center, is one of the internationally authoritative pathology inter-laboratory quality assessment organizations. Our company has consistently focused on its activities and actively participated in its related inter-laboratory quality assessment activities in recent years, achieving excellent results. We are pleased to announce that our company has once again achieved outstanding performance in the 47th round of NordiQC immunohistochemistry inter-laboratory assessment this year:CD117、CEA、CK20、CK-PAN、CyD1andSOX11several antibodies (the first four antibodies have now obtainedCFDARegistration Certificate) demonstrated excellent immunohistochemical staining results and successfully passed this assessment.
Figure 1. Report Card of Maixin Company in the 47th Round of Immunohistochemistry Inter-laboratory Assessment in 2016
It is worth mentioning that our company’sCD117、CEAandSOX11three antibodies performed particularly outstandingly in this activity. In this NordiQC inter-laboratory assessment: among the 272 units participating in theCD117immunohistochemical staining assessment, only14%of the participating units achieved the excellent result of “optimal“; among the 255 units participating in theCEAimmunohistochemical staining assessment, only17%of the participating units achieved the excellent result of “optimal“; among the 255 units participating in theSOX11immunohistochemical staining assessment, only27%of the participating units achieved the excellent result of “optimal” excellent result.
Subsequently, we will compile the performance of Maixin antibodies in this immunohistochemistry inter-laboratory quality assessment activity (including staining images and antibody protocol recommendations) for your reference and selection. Please stay tuned!
